News & Events

Press Releases

Evergen Launches AI-powered Bone Graft Image Processing Software

February 3, 2025

RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine

December 17, 2024

RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction

November 25, 2024

RTI Surgical Completes Acquisition of Collagen Solutions

November 1, 2024

RTI Surgical Celebrates Expansion of Tutoplast® Tissue Sterilization Process Facility

October 30, 2024

RTI Surgical Completes Acquisition of Cook Biotech

January 31, 2024

RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction

November 27, 2023

Empowered Patient Podcast: Customized Allograft and Xenograft Biomaterials for Use in Regenerative Medicine with Olivier Visa, Evergen

March 4, 2025

Healthcare Business Today: The Future of Regenerative Medicine: What’s Next in 2025 and Beyond by Olivier Visa

January 20, 2025

Medical Product Outsourcing: RTI Surgical Rebrands as Evergen, a Regenerative Medicine CDMO by Sam Brusco

December 17, 2024

Upcoming Events

Connect with us at an upcoming event

MD&M West

Anaheim, CA

February 3-5, 2026

Booth 3461

American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting

New Orleans, LA

March 2-6, 2026

Booth 3219

Life Sciences MedTech Summit

Monarch Beach, CA

March 20, 2026

American Assoc. of Neurological Surgeons (AANS)

Huntington Beach, CA

April 10 – 12, 2026

European Federation of Natl Assoc of Orthopaedic & Traumatology (EFORT)

Malaga, Spain

May 4-6, 2026

Booth 4

OMTEC

Chicago, IL

June 9-11, 2026

Booth 1339

MD&M East

Chicago, IL

June 9 – 11, 2026

American Orthopedic Society of Sports Medicine (AOSSM)

Seattle, WA

July 8 – 11, 2026

Booth 902

Leading innovation in regenerative medicine solutions

Press Releases

Evergen Launches AI-powered Bone Graft Image Processing Software

RTI Surgical Transforms into Evergen, a Leading CDMO in Regenerative Medicine

RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction

RTI Surgical Completes Acquisition of Collagen Solutions

RTI Surgical Celebrates Expansion of Tutoplast® Tissue Sterilization Process Facility

RTI Surgical Completes Acquisition of Cook Biotech

RTI Surgical Receives FDA IDE Approval for the Clinical Investigation of Cortiva® Allograft Dermis in Breast Reconstruction

In the News

Empowered Patient Podcast: Customized Allograft and Xenograft Biomaterials for Use in Regenerative Medicine with Olivier Visa, Evergen

Healthcare Business Today: The Future of Regenerative Medicine: What’s Next in 2025 and Beyond by Olivier Visa

Medical Product Outsourcing: RTI Surgical Rebrands as Evergen, a Regenerative Medicine CDMO by Sam Brusco

Upcoming Events

About Evergen

Services

Biomaterials

News & Events

Careers

Contact